ST. PAUL, Minn., May 29, 2019 /PRNewswire/ -- Squarex, a privately held clinical stage pharmaceutical company developing a topical formulation for the prevention of recurrent cold sores and other infections caused by Herpes Simplex Viruses, announced today that it will present at the 2019 ...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]onal-convention-300856348.html